Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Real-life Experience of Brentuximab Vedotin Plus CHP as First-line Treatment of CD30+ Peripheral T-cell Lymphomas in Spain

NCT07624838

Conditions
CD30-Positive Peripheral T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Hospital Universitario A Coruña A Coruña, Spain
  • Hospital Universitari Son Llàtzer Palma de Mallorca, Balearic Islands, Spain
  • Hospital Universitari Son Espases Palma de Mallorca, Balearic Islands, Spain
  • ICO Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
View all 37 locations
View Trial Details
Recruiting

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

NCT05848687

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Valley Children's Hospital Madera, California, United States
View all 24 locations
View Trial Details
Recruiting

A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)

NCT07139873

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +14 more
Locations
  • First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital Nanjing, Jiangsu, China
  • National Clinical Research Center for Blood Diseases, Blood Disease Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin, Tianjin Municipality, China
View Trial Details
Recruiting

Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma

NCT05145400

Conditions
Blood Protein Disorders, Cancer, Cardiovascular Diseases, +13 more
Locations
  • University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
  • Novant Health New Hanover Regional Medical Center Wilmington, North Carolina, United States
View Trial Details
Recruiting

DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)

NCT06539182

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +14 more
Locations
  • Research Site Hefei, Anhui, China
  • Research Site Beijing, Beijing Municipality, China
  • Research Site Beijing, Beijing Municipality, China
  • Research Site Guangzhou, Guandong, China
View all 17 locations
View Trial Details
Recruiting

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

NCT04139304

Conditions
Ann Arbor Stage I Diffuse Large B-Cell Lymphoma, Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, +13 more
Locations
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions